logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US
logo-top-c-r
logo-top-r-w
  • HOME
  • ABOUT MORSE
    • The Team
    • Strategic Partners
      • Lorraine Boyle
      • Dominika Dabrowski
      • Stephen Filbey
      • Brent Korte
    • Careers
  • SERVICES
    • Our Services
    • Strategic Advice
      • MORSE pCPA Assessment
      • MORSE HTA Strategic Advice
    • Analyses
    • Advisory Boards
      • MORSE Advisory Panel (MAP)
    • Training
      • RWE/Innovative Agreements
      • Private Payer
      • Negotiation Simulation
      • Reimbursement Training
    • Reports
      • Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
      • Drugs for Rare Diseases Sub-Report
      • Oncology and Biosimilar Sub-Report
  • NEWS
    • MORSE Signals
    • MORSE Wire
    • Publications
    • What’s New
  • EVENTS
  • LINKS
  • CONTACT US

MORSE Consulting Proudly Participates at the 2018 CADTH Symposium

April 12, 2018
-
Market Access News, What's New
-
Posted by MORSE Team - < 1 min read.

MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place from April 15-17, 2018 in Halifax, Nova Scotia. Further details on MORSE, and its strategic partner’s (Cornerstone Research Group) participation can be found below.

April 16, 2018

 

15:15-16:30 ADT

 

Sherry O’Quinn moderates a panel on oncology drugs with Alex Chambers (CADTH), Scott Gavura (CCO), Elena Lungu (PMPRB), Tanya Potashnik (PMPRB), and Tallal Younis (Dalhousie). The discussion is entitled, “The Growing Cost of Oncology Drugs: Is It Sustainable?”

 

 

15:15-16:30 ADT

 

Brad Alyward participates on a panel on essential medicines moderated by Cornerstone Research Group’s Chris Cameron. The session is entitled, “Essential Medicines In Canada: What is Essential and How Accessible Is It?”

 

 

April 17, 2018

 

13:15 – 14:30 ADT

 

Brad Alyward moderates a panel on outcomes-based agreements with Chad Mitchell (Alberta), Sang-Mi Lee (pCPA Office), Fei Fei Liu (Celgene), and Dr. Muhammad Mamdani (St. Michael’s Hospital). The discussion is entitled, “Can Outcomes-Based Agreements Support Appropriate, Affordable, and Accessible Health Care?”

 

Live Stream for #CADTHsymp

 

Share
Tags
CADTH
CADTHsymp
CCO
Halifax
Oncology
pCPA
Pharmacare
PMPRB
← PREVIOUS POST
pCPA Update as of March 31, 2018
NEXT POST →
pCPA Monthly Trends & Insights – February 2018

Contact Us
MORSE Consulting Inc.
Toronto | Ottawa, Canada
+1-647-717-3179 (Toronto)
+1-613-864-8645 (Ottawa)
info@morseconsulting.ca
Social
Connect & Follow:

New Report

Newsletter – MORSE Signals
Sign up for our free e-mail newsletter service and receive timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.

Sign Up
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. | Site by Directica Media
MORSE Consulting Proudly Participates at the 2018 CADTH Symposium